A Registered Cohort Study on Duchenne Muscular Dystrophy

NCT04012671 · tracked via the Priya Life Science China tracker

Sponsor

Ning Wang, MD., PhD.

Phase

Observational

Started

2019-07-01

Last updated

2021-03-22

Condition(s) studied

Duchenne Muscular Dystrophy

Study summary

Dystrophinopathy is a term of X-linked recessive genetic disease, including Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and the X-linked dilated cardiomyopathy. The aim of this study is to determine the clinical spectrum and natural progression of dystrophinopathy in a prospective multicenter natural history study, to assess the clinical, genetic of patients with dystrophinopathy to optimize clinical management.

Eligibility

Sex

ALL

Min age

2 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Beyond 2 years old * Diagnosis with Duchenne Muscular Dystrophy, and female carriers, genotypically confirmed * Diagnosis should be supported by muscle biopsy, if no genetic confirmation. Exclusion Criteria: * Presence of other clinically significant illness

Primary outcome measure(s)

Age at death — 20 years
the time when patient die

Trial sites (1)

Facility	City	Region	Status
First Affiliated Hospital of Fujian Medical University	Fuzhou	China	Recruiting

More Ning Wang, MD., PhD. trials in China

A Registered Cohort Study on FSHD1 Recruiting

A Registered Cohort Study on Cerebellar Ataxia in the Organization in South-East China for Cerebellar Ataxia Research (OSCCAR) Recruiting

A Registered Cohort Study on Charcot-Marie-Tooth Disease Recruiting

Other trials for the same condition

A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD) Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04012671 on ClinicalTrials.gov ↗ ← All trials in China